Blog
RSS FeedPosted by Michael Wonder on 06 Sep 2021
Leap forward for patients accessing medicines
7 September 2021 - Medicines Australia has secured a 5 year strategic agreement with the Federal Government, centered on earlier ...
Posted by Michael Wonder on 06 Sep 2021
Four million Pfizer doses arrive to super-charge vaccine roll out
6 September 2021 - Four million extra Pfizer-BioNTech (Pfizer) vaccine doses will begin arriving in Australia in days following a historic ...
Posted by Michael Wonder on 06 Sep 2021
New treatment option for schizophrenia Reagila listed on PBS
6 September 2021 - Adults living with schizophrenia will have access to a new treatment option with Reagila (cariprazine), reimbursed ...
Posted by Michael Wonder on 02 Sep 2021
Updated agenda for the November 2021 PBAC meeting
2 September 2021 - The agenda for the November 2021 PBAC meeting has been updated. ...
Posted by Michael Wonder on 31 Aug 2021
Price relief as epilepsy drug PBS listed
1 September 2021 - Australian epilepsy sufferers will now be reimbursed for a drug that reduces uncontrolled seizures, as a ...
Posted by Michael Wonder on 31 Aug 2021
Schedule of Pharmaceutical Benefits - 1 September 2021 update
1 September 2021 - The September 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Aug 2021
Australia is ending its zero-covid strategy
28 August 2021 - “This is not a sustainable way to live in this country,” declared Scott Morrison, Australia’s prime minister, ...
Posted by Michael Wonder on 30 Aug 2021
Review of the National Medicines Policy – call for submissions
30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...
Posted by Michael Wonder on 30 Aug 2021
Public Summary Documents – May 2021 PBAC meeting
27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...
Posted by Michael Wonder on 29 Aug 2021
Breakthrough PBS listings to benefit thousands of Australians
29 August 2021 - From 1 September 2021, thousands of Australians living with schizophrenia, liver disease, lymphoma and anaphylaxis will have ...
Posted by Michael Wonder on 24 Aug 2021
Limited access to 'lifesaving' cystic fibrosis drug Trikafta under Pharmaceutical Benefits Scheme
24 August 2021 - A mother whose son lives with cystic fibrosis says young people are dying as they wait for ...
Posted by Michael Wonder on 20 Aug 2021
Recommendations made by the PBAC – July 2021
20 August 2021 - Recommendations made by the PBAC in July 2021 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 17 Aug 2021
Final terms of reference and public consultation to the post-market review of opiate dependence treatment program medicines
17 August 2021 - The public consultation process for the post-market review of opiate dependence treatment program medicines is now ...
Posted by Michael Wonder on 15 Aug 2021
Australia secures one million Pfizer doses from Poland, with more than half destined for Sydney
15 August 2021 - Poland has come to Australia’s rescue with an extra one million Pfizer doses after the government went ...
Posted by Michael Wonder on 13 Aug 2021
PBS arrangements for tocilizumab shortage
13 August 2021 - The sponsor of tocilizumab (Actemra) Roche has notified the TGA of shortages of multiple presentations of tocilizumab ...